Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 166.41 Million EUR | 8.05% |
| 2022 | 154.01 Million EUR | -6.5% |
| 2021 | 164.71 Million EUR | 12.19% |
| 2020 | 146.82 Million EUR | 16.35% |
| 2019 | 126.18 Million EUR | 18.2% |
| 2018 | 106.75 Million EUR | 45.77% |
| 2017 | 73.23 Million EUR | 55.68% |
| 2016 | 47.04 Million EUR | 45.09% |
| 2015 | 32.42 Million EUR | 1.78% |
| 2014 | 31.85 Million EUR | -4.43% |
| 2013 | 33.33 Million EUR | -4.71% |
| 2012 | 34.98 Million EUR | 8.12% |
| 2011 | 32.35 Million EUR | -4.53% |
| 2010 | 33.89 Million EUR | -5.83% |
| 2009 | 35.99 Million EUR | -9.9% |
| 2008 | 39.94 Million EUR | 10.24% |
| 2007 | 36.23 Million EUR | -2.47% |
| 2006 | 37.15 Million EUR | 34.48% |
| 2005 | 27.62 Million EUR | 5.2% |
| 2004 | 26.26 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 183.3 Million EUR | 0.0% |
| 2024 Q1 | 183.3 Million EUR | 10.15% |
| 2023 Q3 | 166.41 Million EUR | -6.02% |
| 2023 FY | 166.41 Million EUR | 8.05% |
| 2023 Q4 | 166.41 Million EUR | 0.0% |
| 2023 Q1 | 177.07 Million EUR | 14.97% |
| 2023 Q2 | 177.07 Million EUR | -0.0% |
| 2022 FY | 154.01 Million EUR | -6.5% |
| 2022 Q4 | 154.01 Million EUR | 0.0% |
| 2022 Q3 | 154.01 Million EUR | -12.67% |
| 2022 Q2 | 176.36 Million EUR | 0.0% |
| 2022 Q1 | 176.36 Million EUR | 7.07% |
| 2021 Q3 | 164.71 Million EUR | 2.87% |
| 2021 Q1 | 160.12 Million EUR | 9.06% |
| 2021 Q2 | 160.12 Million EUR | 0.0% |
| 2021 Q4 | 164.71 Million EUR | 0.0% |
| 2021 FY | 164.71 Million EUR | 12.19% |
| 2020 Q4 | 146.82 Million EUR | 0.0% |
| 2020 FY | 146.82 Million EUR | 16.35% |
| 2020 Q2 | 164.5 Million EUR | -0.0% |
| 2020 Q1 | 164.5 Million EUR | 30.36% |
| 2020 Q3 | 146.82 Million EUR | -10.75% |
| 2019 Q3 | 126.18 Million EUR | -6.88% |
| 2019 FY | 126.18 Million EUR | 18.2% |
| 2019 Q4 | 126.18 Million EUR | 0.0% |
| 2019 Q2 | 135.51 Million EUR | 0.0% |
| 2019 Q1 | 135.51 Million EUR | 26.93% |
| 2018 Q3 | 106.75 Million EUR | -5.83% |
| 2018 FY | 106.75 Million EUR | 45.77% |
| 2018 Q2 | 113.37 Million EUR | 0.0% |
| 2018 Q4 | 106.75 Million EUR | 0.0% |
| 2018 Q1 | 113.37 Million EUR | 54.8% |
| 2017 FY | 73.23 Million EUR | 55.68% |
| 2017 Q4 | 73.23 Million EUR | 0.0% |
| 2017 Q3 | 73.23 Million EUR | 21.6% |
| 2017 Q2 | 60.22 Million EUR | 0.0% |
| 2017 Q1 | 60.22 Million EUR | 28.02% |
| 2016 Q4 | 47.04 Million EUR | 0.0% |
| 2016 FY | 47.04 Million EUR | 45.09% |
| 2016 Q1 | 47.2 Million EUR | 45.59% |
| 2016 Q2 | 47.2 Million EUR | 0.0% |
| 2016 Q3 | 47.04 Million EUR | -0.35% |
| 2015 Q1 | 39.45 Million EUR | 23.84% |
| 2015 FY | 32.42 Million EUR | 1.78% |
| 2015 Q2 | 39.45 Million EUR | 0.0% |
| 2015 Q3 | 32.42 Million EUR | -17.81% |
| 2015 Q4 | 32.42 Million EUR | 0.0% |
| 2014 Q3 | 31.85 Million EUR | -17.82% |
| 2014 Q1 | 38.76 Million EUR | 16.29% |
| 2014 Q2 | 38.76 Million EUR | 0.0% |
| 2014 FY | 31.85 Million EUR | -4.43% |
| 2014 Q4 | 31.85 Million EUR | 0.0% |
| 2013 Q2 | 37.65 Million EUR | 0.0% |
| 2013 Q4 | 33.33 Million EUR | 0.0% |
| 2013 Q3 | 33.33 Million EUR | -11.47% |
| 2013 FY | 33.33 Million EUR | -4.71% |
| 2013 Q1 | 37.65 Million EUR | 7.64% |
| 2012 Q4 | 34.98 Million EUR | 0.0% |
| 2012 Q2 | 38.25 Million EUR | 0.0% |
| 2012 FY | 34.98 Million EUR | 8.12% |
| 2011 Q2 | 37.93 Million EUR | 0.0% |
| 2011 Q4 | 32.35 Million EUR | 0.0% |
| 2011 FY | 32.35 Million EUR | -4.53% |
| 2010 Q2 | 39.78 Million EUR | 0.0% |
| 2010 FY | 33.89 Million EUR | -5.83% |
| 2010 Q4 | 33.89 Million EUR | 0.0% |
| 2009 FY | 35.99 Million EUR | -9.9% |
| 2009 Q4 | 35.99 Million EUR | 0.0% |
| 2008 FY | 39.94 Million EUR | 10.24% |
| 2007 FY | 36.23 Million EUR | -2.47% |
| 2006 FY | 37.15 Million EUR | 34.48% |
| 2005 FY | 27.62 Million EUR | 5.2% |
| 2004 FY | 26.26 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cegedim SA | 629.51 Million EUR | 73.564% |
| Guerbet SA | 646.97 Million EUR | 74.277% |
| Nexus AG | 153.13 Million EUR | -8.675% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | 70.615% |
| Revenio Group Oyj | 37.6 Million EUR | -342.604% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 90.99% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 97.622% |
| LNA Santé SA | 1.19 Billion EUR | 86.116% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.417% |
| Medios AG | 125.94 Million EUR | -32.135% |
| Stratec SE | 246.2 Million EUR | 32.406% |